» Articles » PMID: 25452272

The Evolution of Thymic Lymphomas in P53 Knockout Mice

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2014 Dec 3
PMID 25452272
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Germline deletion of the p53 gene in mice gives rise to spontaneous thymic (T-cell) lymphomas. In this study, the p53 knockout mouse was employed as a model to study the mutational evolution of tumorigenesis. The clonality of the T-cell repertoire from p53 knockout and wild-type thymic cells was analyzed at various ages employing TCRβ sequencing. These data demonstrate that p53 knockout thymic lymphomas arose in an oligoclonal fashion, with tumors evolving dominant clones over time. Exon sequencing of tumor DNA revealed that all of the independently derived oligoclonal mouse tumors had a deletion in the Pten gene prior to the formation of the TCRβ rearrangement, produced early in development. This was followed in each independent clone of the thymic lymphoma by the amplification or overexpression of cyclin Ds and Cdk6. Alterations in the expression of Ikaros were common and blocked further development of CD-4/CD-8 T cells. While the frequency of point mutations in the genome of these lymphomas was one per megabase, there were a tremendous number of copy number variations producing the tumors' driver mutations. The initial inherited loss of p53 functions appeared to delineate an order of genetic alterations selected for during the evolution of these thymic lymphomas.

Citing Articles

Trp53 Deletion Promotes Exacerbated Colitis, Facilitates Lgr5+ Cancer Stem Cell Expansion, and Fuels Tumorigenesis in AOM/DSS-Induced Colorectal Cancer.

Cunha A, Delou J, Barbosa P, Conceicao J, Souza K, Chagas V Int J Mol Sci. 2024; 25(20).

PMID: 39456736 PMC: 11507199. DOI: 10.3390/ijms252010953.


Emerging strategies to investigate the biology of early cancer.

Zhou R, Tang X, Wang Y Nat Rev Cancer. 2024; 24(12):850-866.

PMID: 39433978 DOI: 10.1038/s41568-024-00754-y.


Understanding the complexity of p53 in a new era of tumor suppression.

Liu Y, Su Z, Tavana O, Gu W Cancer Cell. 2024; 42(6):946-967.

PMID: 38729160 PMC: 11190820. DOI: 10.1016/j.ccell.2024.04.009.


Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?.

Janic A, Abad E, Amelio I Cell Death Differ. 2024; 32(1):1-8.

PMID: 38379088 PMC: 11742645. DOI: 10.1038/s41418-024-01259-9.


Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.

Brennan M, Brinkmann K, Romero Sola G, Healey G, Gibson L, Gangoda L Cell Death Differ. 2023; 31(2):159-169.

PMID: 38110554 PMC: 10850490. DOI: 10.1038/s41418-023-01250-w.


References
1.
Chilosi M, Doglioni C, Yan Z, Lestani M, Menestrina F, Sorio C . Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol. 1998; 152(1):209-17. PMC: 1858129. View

2.
Levine A, Momand J, Finlay C . The p53 tumour suppressor gene. Nature. 1991; 351(6326):453-6. DOI: 10.1038/351453a0. View

3.
Sathirapongsasuti J, Lee H, Horst B, Brunner G, Cochran A, Binder S . Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics. 2011; 27(19):2648-54. PMC: 3179661. DOI: 10.1093/bioinformatics/btr462. View

4.
Ferrando A, Neuberg D, Staunton J, Loh M, Huard C, Raimondi S . Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002; 1(1):75-87. DOI: 10.1016/s1535-6108(02)00018-1. View

5.
Weng A, Ferrando A, Lee W, Morris 4th J, Silverman L, Sanchez-Irizarry C . Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306(5694):269-71. DOI: 10.1126/science.1102160. View